Synthetic chymotrypsin-labile peptide, used in diagnosis of exocrine pancreatic disease. Prepn: P. L. De Benneville, N. J. Greenberger, DE 2156835; eidem, US 3801562 (1972, 1974 both to Rohm & Haas). Synthesis, in vitro and in vivo data: P. L. De Benneville et al., J. Med. Chem. 15, 1098 (1972). Early clinical studies: K. Gyr et al., Schweiz. Med. Wochenschr. 105, 1717 (1975); W. Bornschein et al., Clin. Chim. Acta 67, 21 (1976). Pediatric study: G. Dockter et al., Eur. J. Pediatr. 135, 277 (1981). Human toxicity study, effects of renal insufficiency on pancreatic function test: C. Lang et al., J. Clin. Chem. Clin. Biochem. 18, 551 (1980).
Diagnostic aid (pancreatic function).
Diagnostic Aid